A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy Fleischmann, Marc C. Levesque, Charles G. Peterfy et al.|Arthritis & Rheumatology|2019Cited by 209
Identification of disease-stage therapeutic responses of mesenchymal stromal cells retrieved from murine osteoarthritic jointsAna Ivanovska, Mary Murphy, P. Mancuso et al.|Frontiers in Cell and Developmental Biology|2025Cited by 3